Perigon Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.3M Sell
87,088
-633
-0.7% -$147K 0.39% 54
2025
Q4
$18.2M Buy
87,721
+14,141
+19% +$2.8M 0.32% 65
2025
Q3
$13.6M Buy
73,580
+2,006
+3% +$344K 0.28% 69
2025
Q2
$10.9M Sell
71,574
-14,539
-17% -$2.23M 0.26% 82
2025
Q1
$14.3M Sell
86,113
-2,943
-3% -$460K 0.37% 56
2024
Q4
$13.2M Sell
89,056
-3,408
-4% -$528K 0.32% 64
2024
Q3
$15M Buy
92,464
+2,992
+3% +$477K 0.4% 49
2024
Q2
$13.1M Sell
89,472
-9,759
-10% -$1.45M 0.38% 54
2024
Q1
$15.7M Sell
99,231
-17,918
-15% -$2.85M 0.48% 43
2023
Q4
$18.4M Buy
117,149
+20,065
+21% +$3.08M 0.6% 33
2023
Q3
$15.1M Sell
97,084
-6,196
-6% -$1.02M 0.61% 32
2023
Q2
$17.1M Buy
103,280
+40,975
+66% +$6.61M 0.67% 31
2023
Q1
$9.66M Sell
62,305
-652
-1% -$105K 0.55% 37
2022
Q4
$11.1M Buy
62,957
+12,361
+24% +$2.13M 0.69% 27
2022
Q3
$8.27M Buy
50,596
+3,695
+8% +$625K 0.71% 24
2022
Q2
$8.32M Buy
46,901
+1,521
+3% +$271K 0.7% 24
2022
Q1
$8.04M Buy
45,380
+1,277
+3% +$217K 0.57% 31
2021
Q4
$7.54M Buy
44,103
+3,210
+8% +$526K 0.54% 33
2021
Q3
$6.6M Buy
40,893
+76
+0.2% +$13K 0.57% 34
2021
Q2
$6.72M Buy
40,817
+21
+0.1% +$3.48K 0.6% 32
2021
Q1
$6.71M Buy
40,796
+4,033
+11% +$653K 0.68% 30
2020
Q4
$5.79M Sell
36,763
-1,151
-3% -$170K 0.67% 29
2020
Q3
$5.64M Sell
37,914
-1,056
-3% -$156K 0.79% 24
2020
Q2
$5.48M Buy
38,970
+1,171
+3% +$171K 0.87% 23
2020
Q1
$5.34M Buy
37,799
+6,558
+21% +$930K 0.99% 22
2019
Q4
$4.5M Sell
31,241
-2,185
-7% -$296K 0.92% 26
2019
Q3
$4.44M Sell
33,426
-6,571
-16% -$866K 1.04% 25
2019
Q2
$5.57M Sell
39,997
-3,361
-8% -$465K 1.3% 17
2019
Q1
$6.05M Sell
43,358
-8,499
-16% -$1.14M 1.41% 14
2018
Q4
$6.27M Buy
51,857
+12,060
+30% +$1.68M 1.6% 11
2018
Q3
$5.5M Buy
39,797
+1,197
+3% +$159K 1.35% 13
2018
Q2
$4.68M Buy
38,600
+4,025
+12% +$502K 1.41% 14
2018
Q1
$4.43M Buy
34,575
+524
+2% +$70.8K 1.63% 12
2017
Q4
$4.76M Sell
34,051
-3,042
-8% -$424K 1.78% 13
2017
Q3
$4.82M Sell
37,093
-21,115
-36% -$2.8M 1.56% 13
2017
Q2
$7.7M Sell
58,208
-2,689
-4% -$343K 1.68% 9
2017
Q1
$7.58M Buy
60,897
+2,715
+5% +$324K 1.61% 9
2016
Q4
$7.25M Buy
58,182
+10,176
+21% +$1.18M 1.58% 8
2016
Q3
$5.67M Buy
48,006
+5,356
+13% +$650K 1.46% 12
2016
Q2
$5.17M Buy
42,650
+7,355
+21% +$836K 1.37% 13
2016
Q1
$3.88M Hold
35,295
1.21% 22
2015
Q4
$3.63M Buy
35,295
+1,681
+5% +$169K 1% 26
2015
Q3
$3.14M Sell
33,614
-34
-0.1% -$3.29K 0.93% 21
2015
Q2
$3.28M Sell
33,648
-864
-3% -$86.5K 0.86% 24
2015
Q1
$3.47M Buy
34,512
+15,720
+84% +$1.6M 0.95% 21
2014
Q4
$1.97M Buy
18,792
+1,412
+8% +$149K 0.59% 52
2014
Q3
$1.85M Sell
17,380
-18,108
-51% -$1.88M 0.55% 54
2014
Q2
$3.71M Buy
35,488
+544
+2% +$55K 1.06% 22
2014
Q1
$3.43M Buy
34,944
+879
+3% +$81.5K 1.89% 11
2013
Q4
$3.12M Buy
+34,065
New +$3.14M 1.73% 16

Other funds holding JNJ

Perigon Wealth Management's JNJ Position: Q1 2026 in Review

Perigon Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.72% in Q1 2026, selling an estimated $147K and leaving 87,088 shares worth $21.3M. The position accounts for 0.39% of the portfolio, ranked #54.

Perigon Wealth Management first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Perigon Wealth Management held 87,088 shares of Johnson & Johnson worth $21.3M as of Q1 2026.
  • Perigon Wealth Management sold 633 Johnson & Johnson shares in Q1 2026, an estimated $147K.
  • Johnson & Johnson made up 0.39% of Perigon Wealth Management's portfolio in Q1 2026, its #54 holding.
  • Perigon Wealth Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.